Star Imaging and Path Lab Limited (BOM:544482)

Market Cap	1.22B
Revenue (ttm)	885.27M +7.2%
Net Income	192.80M +21.1%
EPS	11.05
Shares Out	17.42M
PE Ratio	6.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,000
Open	72.90
Previous Close	69.99
Day's Range	72.00 - 72.90
52-Week Range	46.00 - 152.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 22, 2026

About Star Imaging and Path Lab

Star Imaging and Path Lab Limited operates as a diagnostic testing network and provides diagnostic imaging services and clinical laboratory tests in India. It offers diagnostic and radiology services, which includes X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, 4D and 5D ultrasounds, bone mineral densitometry, mammography, and orthopantomogram, surgical/anatomic pathology; pathology services, includes hematology, polymerase chain reaction, clinical pathology, histopathology, cytopathology, treadmill stress test...

• Industry: Medical Laboratories
• Founded: 1978
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544482

Financial Performance

In fiscal year 2026, Star Imaging and Path Lab's revenue was 895.23 million, an increase of 7.21% compared to the previous year's 835.00 million. Earnings were 192.80 million, an increase of 21.06%.